These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37037429)

  • 1. Development of a Scorecard to Monitor Progress toward National Cholera Elimination: Its Application in Uganda.
    Bwire G; Sack DA; Lunkuse SM; Ongole F; Ngwa MC; Namanya DB; Nsungwa J; Aceng Ocero JR; Mwebesa HG; Muruta A; Nakinsige A; Kisakye A; Kalyebi P; Kemirembe J; Makumbi I; Kagirita A; Ampeire I; Mutegeki D; Matseketse D; Debes AK; Orach CG
    Am J Trop Med Hyg; 2023 May; 108(5):954-962. PubMed ID: 37037429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholera and COVID-19 pandemic prevention in multiple hotspot districts of Uganda: vaccine coverage, adverse events following immunization and WASH conditions survey.
    Bwire G; Kisakye A; Amulen E; Bwanika JB; Badebye J; Aanyu C; Nakirya BD; Okello A; Okello SA; Bukenya JN; Orach CG
    BMC Infect Dis; 2023 Jul; 23(1):487. PubMed ID: 37479986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying cholera "hotspots" in Uganda: An analysis of cholera surveillance data from 2011 to 2016.
    Bwire G; Ali M; Sack DA; Nakinsige A; Naigaga M; Debes AK; Ngwa MC; Brooks WA; Garimoi Orach C
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006118. PubMed ID: 29284003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of surveys to evaluate an integrated oral cholera vaccine campaign in response to a cholera outbreak in Hoima district, Uganda.
    Bwire G; Roskosky M; Ballard A; Brooks WA; Okello A; Rafael F; Ampeire I; Orach CG; Sack DA
    BMJ Open; 2020 Dec; 10(12):e038464. PubMed ID: 33303438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A reactive vaccination campaign with single dose oral cholera vaccine (OCV) during a cholera outbreak in Cameroon.
    Amani A; Tatang CA; Bayiha CN; Woung M; Ngo Bama S; Nangmo A; Mbang MA; Epee Douba E
    Vaccine; 2021 Feb; 39(8):1290-1296. PubMed ID: 33494966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethiopia National Cholera Elimination Plan 2022-2028: Experiences, Challenges, and the Way Forward.
    Hussen M; Worku Demlie Y; Edosa M; Kebede M; Wossen M; Mulugeta Chane A; Abate G; Hailu Asfaw W; Hailu D; Teferi M; Jeon Y; Gedefaw A; Park SE
    Clin Infect Dis; 2024 Jul; 79(Supplement_1):S1-S7. PubMed ID: 38996038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The burden of cholera in Uganda.
    Bwire G; Malimbo M; Maskery B; Kim YE; Mogasale V; Levin A
    PLoS Negl Trop Dis; 2013; 7(12):e2545. PubMed ID: 24340106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Programmatic Preparations and challenges for OCV introduction in India.
    Haldar P
    Vaccine; 2020 Feb; 38 Suppl 1():A175-A177. PubMed ID: 31307875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral cholera vaccine in cholera prevention and control, Malawi.
    M'bangombe M; Pezzoli L; Reeder B; Kabuluzi S; Msyamboza K; Masuku H; Ngwira B; Cavailler P; Grandesso F; Palomares A; Beck N; Shaffer A; MacDonald E; Senbete M; Lessler J; Moore SM; Azman AS
    Bull World Health Organ; 2018 Jun; 96(6):428-435. PubMed ID: 29904226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current and future cholera vaccines.
    Shaikh H; Lynch J; Kim J; Excler JL
    Vaccine; 2020 Feb; 38 Suppl 1():A118-A126. PubMed ID: 31879125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of oral cholera vaccines in an outbreak in Vietnam: a case control study.
    Anh DD; Lopez AL; Thiem VD; Grahek SL; Duong TN; Park JK; Kwon HJ; Favorov M; Hien NT; Clemens JD
    PLoS Negl Trop Dis; 2011 Jan; 5(1):e1006. PubMed ID: 21283616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral cholera vaccination coverage in an acute emergency setting in Somalia, 2017.
    Lubogo M; Mohamed AM; Ali AH; Ali AH; Popal GR; Kiongo D; Bile KM; Malik M; Abubakar A
    Vaccine; 2020 Feb; 38 Suppl 1():A141-A147. PubMed ID: 31980193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The projected impact of geographic targeting of oral cholera vaccination in sub-Saharan Africa: A modeling study.
    Lee EC; Azman AS; Kaminsky J; Moore SM; McKay HS; Lessler J
    PLoS Med; 2019 Dec; 16(12):e1003003. PubMed ID: 31825965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral Cholera Vaccination Delivery Cost in Low- and Middle-Income Countries: An Analysis Based on Systematic Review.
    Mogasale V; Ramani E; Wee H; Kim JH
    PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005124. PubMed ID: 27930668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rapid qualitative assessment of oral cholera vaccine anticipated acceptability in a context of resistance towards cholera intervention in Nampula, Mozambique.
    Démolis R; Botão C; Heyerdahl LW; Gessner BD; Cavailler P; Sinai C; Magaço A; Le Gargasson JB; Mengel M; Guillermet E
    Vaccine; 2018 Oct; 36(44):6497-6505. PubMed ID: 29174106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility and acceptability of oral cholera vaccine mass vaccination campaign in response to an outbreak and floods in Malawi.
    Msyamboza KP; M'bang'ombe M; Hausi H; Chijuwa A; Nkukumila V; Kubwalo HW; Desai S; Pezzoli L; Legros D
    Pan Afr Med J; 2016; 23():203. PubMed ID: 27347292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges for Programmatic Implementation of Oral Cholera Vaccine in India.
    Chakraborty D; Kanungo S; Kumar Nandy R; Kumar Deb A; Kumar Mukhopadhyay A; Dutta S
    J Infect Dis; 2021 Dec; 224(12 Suppl 2):S754-S758. PubMed ID: 34668559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of cholera hotspots in Zambia: A spatiotemporal analysis of cholera data from 2008 to 2017.
    Mwaba J; Debes AK; Shea P; Mukonka V; Chewe O; Chisenga C; Simuyandi M; Kwenda G; Sack D; Chilengi R; Ali M
    PLoS Negl Trop Dis; 2020 Apr; 14(4):e0008227. PubMed ID: 32294084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-emptive oral cholera vaccine (OCV) mass vaccination campaign in Cuamba District, Niassa Province, Mozambique: feasibility, vaccination coverage and delivery costs using CholTool.
    Elias Chitio JJ; Baltazar CS; Langa JP; Baloi LD; Mboane RBJ; Manuel JA; Assane S; Omar A; Manso M; Capitine I; Van Rensburg C; Luiz N; Mogasale V; Marks F; Park SE; Beck NS
    BMJ Open; 2022 Sep; 12(9):e053585. PubMed ID: 36547726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of oral cholera vaccines in cholera-endemic countries: A mathematical modeling study.
    Kim JH; Mogasale V; Burgess C; Wierzba TF
    Vaccine; 2016 Apr; 34(18):2113-20. PubMed ID: 26993337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.